NATICK, Mass.--(BUSINESS WIRE)---- $ALUR--Allurion Technologies, Inc. (âAllurionâ or the âCompanyâ) (NYSE: ALUR), a pioneer in metabolically healthy weight loss, today announced that it will report financial results for the second quarter 2025 on Wednesday, August 13, 2025. Company management will host a conference call to discuss financial results and provide a business update on the same day at 8:30 AM ET. To access the conference call by telephone, please dial (888) 330-3417 (domestic) or +1 (646) 960
Related Questions
What is the market's reaction to the earnings release and conference call, and how might it affect the stock price in the short term?
Are there any risks or uncertainties highlighted in the earnings call that could impact the company's future performance?
How does Allurion's performance this quarter compare to its key competitors in the weightâloss and metabolic health space?
What were Allurion's Q2 2025 revenue and earnings compared to the previous quarter and year?
Are there any notable changes in the company's operating expenses, margin, or cash flow?
Did the company address any regulatory or reimbursement developments that could affect its business model?
Did the company announce any new partnerships, product launches, or strategic initiatives that could impact growth?
How did the Q2 2025 results compare to analyst consensus estimates and guidance?
What is the outlook for future quarters and does the company provide any updated guidance?
What is the status of the company's pipeline and any upcoming product milestones that could drive future revenue?